GE Healthcare announced that it has received FDA 510(k) clearance for its Precision DL deep learning image processing software.
Precision DL utilizes deep learning, a subset of AI and machine learning, to improve the image quality of the company’s PET/CT, Omni Legend, enabling faster scan times and better detection of small lesions. The software is the company’s latest addition to his Effortless Recon DL portfolio.
“One of the main benefits of fully moving to a future of AI and deep learning is that it will make cutting-edge imaging more accessible to more healthcare settings than ever before,” said Dr. said Jan Makela, President and CEO, Imaging. GE Healthcare said in a statement:
the bigger trend
in January, GE completed the spin-off of its healthcare division, GE Healthcare, and began trading on the Nasdaq as a standalone company under the GEHC ticker. GE announced its first spinoff in 2021 as part of a larger effort to split GE into three companies: GE Healthcare, GE Aerospace, and energy-focused GE Vernova.
In the same month, GE Healthcare announced: has hired Dr. Taha Kashout, formerly of Amazon Web Services, as its first Chief Technology Officer. It also acquired France’s IMACTIS, which develops computerized tomography (CT) intervention-guided technology.
In February, the company announced that it had signed an acquisition agreement. Caption Health is the maker of AI-enabled ultrasound guidance software.
Last month, the health tech giant First independent company to report quarterly results, with net income of $372 million in the first quarter ($389 million in the same period last year) and revenue of $4.7 billion, up 8% year-over-year .
